These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12570068)

  • 41. Role of atypical antipsychotics in rapid cycling bipolar disorder: a review of the literature.
    Zupancic ML
    Ann Clin Psychiatry; 2011 May; 23(2):141-9. PubMed ID: 21547275
    [TBL] [Abstract][Full Text] [Related]  

  • 42. What makes a drug a primary mood stabilizer?
    Keck PE; McElroy SL; Richtand N; Tohen M
    Mol Psychiatry; 2002; 7 Suppl 1():S8-14. PubMed ID: 11986990
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antipsychotic drugs in bipolar disorder.
    Ertugrul A; Meltzer HY
    Int J Neuropsychopharmacol; 2003 Sep; 6(3):277-84. PubMed ID: 12974994
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Role of the cholinergic muscarinic system in bipolar disorder and related mechanism of action of antipsychotic agents.
    Bymaster FP; Felder CC
    Mol Psychiatry; 2002; 7 Suppl 1():S57-63. PubMed ID: 11986996
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stabilization of mood from below versus above baseline in bipolar disorder: a new nomenclature.
    Ketter TA; Calabrese JR
    J Clin Psychiatry; 2002 Feb; 63(2):146-51. PubMed ID: 11874216
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A mood stabilizer with risperidone or haloperidol for mania.
    Andrade C
    Am J Psychiatry; 2004 Nov; 161(11):2140. PubMed ID: 15514435
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of clinical response to active drugs and placebo on antipsychotics and mood stabilizers relative efficacy for bipolar depression and mania: A meta-regression analysis.
    Bartoli F; Clerici M; Di Brita C; Riboldi I; Crocamo C; Carrà G
    J Psychopharmacol; 2018 Apr; 32(4):416-422. PubMed ID: 29338576
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression: acute versus long-term data.
    Dell'Osso B; Ketter TA
    Int Clin Psychopharmacol; 2013 Nov; 28(6):297-304. PubMed ID: 24081199
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Risperidone treatment of refractory acute mania.
    Goodnick PJ
    J Clin Psychiatry; 1995 Sep; 56(9):431-2. PubMed ID: 7545160
    [No Abstract]   [Full Text] [Related]  

  • 50. Atypical antipsychotics for the treatment of bipolar disorder: more shadows than lights.
    Gentile S
    CNS Drugs; 2007; 21(5):367-87. PubMed ID: 17447826
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Atypical antipsychotics for acute manic and mixed episodes in children and adolescents with bipolar disorder: efficacy and tolerability.
    Singh MK; Ketter TA; Chang KD
    Drugs; 2010 Mar; 70(4):433-42. PubMed ID: 20205485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antipsychotic medications in the treatment of bipolar disorder.
    Surja AA; Tamas RL; El-Mallakh RS
    Curr Drug Targets; 2006 Sep; 7(9):1217-24. PubMed ID: 17017897
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder.
    Houtepen LC; van Bergen AH; Vinkers CH; Boks MP
    Epigenomics; 2016 Feb; 8(2):197-208. PubMed ID: 26792232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparative effectiveness of monotherapy with mood stabilizers versus second generation (atypical) antipsychotics for the treatment of bipolar disorder in children and adolescents.
    Chen H; Mehta S; Aparasu R; Patel A; Ochoa-Perez M
    Pharmacoepidemiol Drug Saf; 2014 Mar; 23(3):299-308. PubMed ID: 24459113
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Bipolar depression: Managing patients with second generation antipsychotics.
    Avery LM; Drayton SJ
    Int J Psychiatry Med; 2016; 51(2):145-59. PubMed ID: 27079776
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aspirin, arachidonic acid and the regulation of mood.
    Bazinet RP
    Prostaglandins Leukot Essent Fatty Acids; 2010 Jan; 82(1):7-8. PubMed ID: 19910174
    [No Abstract]   [Full Text] [Related]  

  • 57. Atypical antipsychotics in the treatment of bipolar disorder.
    Strakowski SM; Del Bello MP; Adler CM; Keck PE
    Expert Opin Pharmacother; 2003 May; 4(5):751-60. PubMed ID: 12739998
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of Mixed Features in Bipolar Disorder: an Updated View.
    Chakrabarty T; Keramatian K; Yatham LN
    Curr Psychiatry Rep; 2020 Feb; 22(3):15. PubMed ID: 32025903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Emerging options in the treatment of bipolar disorders.
    Berk M; Segal J; Janet L; Vorster M
    Drugs; 2001; 61(10):1407-14. PubMed ID: 11558830
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Atypical antipsychotics as enhancement therapy in rapid cycling mood states: a case study.
    Novac A
    Ann Clin Psychiatry; 1998 Sep; 10(3):107-11. PubMed ID: 9781473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.